Condition
Glenohumeral Arthritis
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06735027Not ApplicableRecruitingPrimary
Corticosteroid Injection Versus Nerve Block
NCT04309344Not ApplicableUnknownPrimary
Biological Effects of a Bipolar Radiofrequency-based Device Over Shoulder Cartilage
NCT03958227Not ApplicableCompletedPrimary
Investigation The Efficacy of Manual Therapy and Exercise in Patients With Glenohumeral Arthritis
NCT03219983Phase 4TerminatedPrimary
Pain Management After Total Shoulder Arthroplasty
NCT00765037Completed
Retrospective Encore Reverse Shoulder Prosthesis Study
Showing all 5 trials